View CNVs/SVs
View by Evidence Type: All (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:16 ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
| CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
|---|---|---|---|---|---|---|---|
| Case | Control | ||||||
| AutCNV0004983 | 16 | 16q23.3 | - | - | - | CNVs Only Present In Patients; de novo CNVs; | Sanders SJ, 2015 |
| AutCNV0005001 | 16 | 16q12.2 | loss | - | - | CNVs Only Present In Patients; | Al-Mamari W, 2015 |
| AutCNV0005025 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
| AutCNV0005026 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
| AutCNV0005027 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
| AutCNV0005028 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
| AutCNV0005036 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; | Berman JI, 2015 |
| AutCNV0005049 | 16 | 16p12.3 | loss | - | - | CNVs Only Present In Patients; | Jiménez-Barrón LT, 2015 |
| AutCNV0005052 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; | Duyzend MH, 2016 |
| AutCNV0005053 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Duyzend MH, 2016 |
| AutCNV0005054 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Duyzend MH, 2016 |
| AutCNV0005079 | 16 | 16p13.11 | gain | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Siu WK, 2016 |
| AutCNV0005082 | 16 | 16p13.11 | gain | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Siu WK, 2016 |
| AutCNV0005083 | 16 | 16p13.11 | gain | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Siu WK, 2016 |
| AutCNV0005086 | 16 | 16p13.11 | gain | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Siu WK, 2016 |
| AutCNV0005107 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Nava C, 2015 |
| AutCNV0005118 | 16 | 16p13.3 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 |
| AutCNV0005138 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Soueid J, 2016 |
| AutCNV0005159 | 16 | 16p13.11 | gain | - | - | CNVs Only Present In Patients; | Pinto AM, 2015 |
| AutCNV0005161 | 16 | 16p13.11 | gain | 1 | - | CNVs Only Present In Patients; | Brownstein CA, 2016 |
| AutCNV0005629 | 16 | 16 | - | - | - | CNVs Only Present In Patients; | Krumm N, 2015 |
| AutCNV0005632 | 16 | 16 | - | - | - | de novo CNVs; | Krumm N, 2015 |
| AutCNV0005646 | 16 | 16 | - | - | - | CNVs Only Present In Patients; | Krumm N, 2015 |
| AutCNV0005676 | 16 | 16 | - | - | - | Krumm N, 2015 | |
| AutCNV0005678 | 16 | 16 | - | - | - | Krumm N, 2015 | |